Hassett: White House may review AI models ‘like an FDA drug’

National Economic Council Director Kevin Hassett said Wednesday the White House is considering an enforcement bid that would necessitate AI models to spell done an valuation process akin to that utilized by the Food and Drug Administration (FDA). The imaginable bid comes arsenic the Trump medication is grappling with Mythos, a caller precocious AI model…